Cargando…

Double-blind, randomized controlled trial comparing the use of microneedling alone versus chemical peeling alone versus a combination of microneedling and chemical peeling in the treatment of atrophic post-acne scars. An assessment of clinical effectiveness and patients’ quality-of-life

INTRODUCTION: Acne vulgaris is a common, chronic disease. One of the most commonly encountered complications of acne is permanent atrophic scarring. Treatment of atrophic scars includes fillers, dermabrasion, laser resurfacing, microneedling and peelings and it is often difficult to treat. In our do...

Descripción completa

Detalles Bibliográficos
Autores principales: Pakla-Misiur, Agata, Grochowiec, Marcelina, Lesiak, Aleksandra, Bednarski, Igor A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501429/
https://www.ncbi.nlm.nih.gov/pubmed/34658706
http://dx.doi.org/10.5114/ada.2021.108913
_version_ 1784580680979578880
author Pakla-Misiur, Agata
Grochowiec, Marcelina
Lesiak, Aleksandra
Bednarski, Igor A.
author_facet Pakla-Misiur, Agata
Grochowiec, Marcelina
Lesiak, Aleksandra
Bednarski, Igor A.
author_sort Pakla-Misiur, Agata
collection PubMed
description INTRODUCTION: Acne vulgaris is a common, chronic disease. One of the most commonly encountered complications of acne is permanent atrophic scarring. Treatment of atrophic scars includes fillers, dermabrasion, laser resurfacing, microneedling and peelings and it is often difficult to treat. In our double-blind randomized controlled trial (RCT), we investigated the synergistic effect of microneedling with the application of trichloroacetic acid, kojic acid and hydrogen peroxide in the treatment of atrophic acne scars. AIM: To assess the clinical effectiveness and patients’ quality-of-life (HRQoL) after three types of atrophic post-acne scar treatment, namely microneedling alone (MN) vs chemical peeling alone (CP) vs. a combination of microneedling and chemical peeling (MN + CP). MATERIAL AND METHODS: A total of 120 patients were enrolled into the study following strict inclusion/exclusion criteria and randomized into the three treatment groups – MN, CP (a combination of trichloroacetic acid, kojic acid and hydrogen peroxide), and MN + CP. According to a preapproved protocol, each patient underwent four treatment sessions, each spread 20 days apart. Both pre- and post-treatment clinical status (using the Goodman-Baron scale; two expert raters blinded to the treatment used) and patients’ HRQoL (using the Dermatology Life Quality Index) were assessed. RESULTS: During the 5-month recruitment period, a total of 120 patients were approached and agreed to take part in the study (94 females – 78.3% and 26 males) (mean age of 30.14 ±3.64 years; range: 18–45 years). Only in the MN + CP group there was a statistically significant improvement according to the G-B scale post-treatment (2.87 ±0.83 vs. 2.03 ±1.16 respectively; p = 0.0005). Patients in all three treatment groups experienced a statistically significant improvement in their HRQoL post-treatment (all p’s < 0.05). CONCLUSIONS: A combination of microneedling and chemical peeling produces the best, objectively measured effects in the treatment of atrophic post-acne scars. All examined treatments, even if not producing a clinically significant treatment outcome, improve patients’ HRQoL.
format Online
Article
Text
id pubmed-8501429
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-85014292021-10-14 Double-blind, randomized controlled trial comparing the use of microneedling alone versus chemical peeling alone versus a combination of microneedling and chemical peeling in the treatment of atrophic post-acne scars. An assessment of clinical effectiveness and patients’ quality-of-life Pakla-Misiur, Agata Grochowiec, Marcelina Lesiak, Aleksandra Bednarski, Igor A. Postepy Dermatol Alergol Original Paper INTRODUCTION: Acne vulgaris is a common, chronic disease. One of the most commonly encountered complications of acne is permanent atrophic scarring. Treatment of atrophic scars includes fillers, dermabrasion, laser resurfacing, microneedling and peelings and it is often difficult to treat. In our double-blind randomized controlled trial (RCT), we investigated the synergistic effect of microneedling with the application of trichloroacetic acid, kojic acid and hydrogen peroxide in the treatment of atrophic acne scars. AIM: To assess the clinical effectiveness and patients’ quality-of-life (HRQoL) after three types of atrophic post-acne scar treatment, namely microneedling alone (MN) vs chemical peeling alone (CP) vs. a combination of microneedling and chemical peeling (MN + CP). MATERIAL AND METHODS: A total of 120 patients were enrolled into the study following strict inclusion/exclusion criteria and randomized into the three treatment groups – MN, CP (a combination of trichloroacetic acid, kojic acid and hydrogen peroxide), and MN + CP. According to a preapproved protocol, each patient underwent four treatment sessions, each spread 20 days apart. Both pre- and post-treatment clinical status (using the Goodman-Baron scale; two expert raters blinded to the treatment used) and patients’ HRQoL (using the Dermatology Life Quality Index) were assessed. RESULTS: During the 5-month recruitment period, a total of 120 patients were approached and agreed to take part in the study (94 females – 78.3% and 26 males) (mean age of 30.14 ±3.64 years; range: 18–45 years). Only in the MN + CP group there was a statistically significant improvement according to the G-B scale post-treatment (2.87 ±0.83 vs. 2.03 ±1.16 respectively; p = 0.0005). Patients in all three treatment groups experienced a statistically significant improvement in their HRQoL post-treatment (all p’s < 0.05). CONCLUSIONS: A combination of microneedling and chemical peeling produces the best, objectively measured effects in the treatment of atrophic post-acne scars. All examined treatments, even if not producing a clinically significant treatment outcome, improve patients’ HRQoL. Termedia Publishing House 2021-09-17 2021-08 /pmc/articles/PMC8501429/ /pubmed/34658706 http://dx.doi.org/10.5114/ada.2021.108913 Text en Copyright: © 2021 Termedia Sp. z o. o. https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Original Paper
Pakla-Misiur, Agata
Grochowiec, Marcelina
Lesiak, Aleksandra
Bednarski, Igor A.
Double-blind, randomized controlled trial comparing the use of microneedling alone versus chemical peeling alone versus a combination of microneedling and chemical peeling in the treatment of atrophic post-acne scars. An assessment of clinical effectiveness and patients’ quality-of-life
title Double-blind, randomized controlled trial comparing the use of microneedling alone versus chemical peeling alone versus a combination of microneedling and chemical peeling in the treatment of atrophic post-acne scars. An assessment of clinical effectiveness and patients’ quality-of-life
title_full Double-blind, randomized controlled trial comparing the use of microneedling alone versus chemical peeling alone versus a combination of microneedling and chemical peeling in the treatment of atrophic post-acne scars. An assessment of clinical effectiveness and patients’ quality-of-life
title_fullStr Double-blind, randomized controlled trial comparing the use of microneedling alone versus chemical peeling alone versus a combination of microneedling and chemical peeling in the treatment of atrophic post-acne scars. An assessment of clinical effectiveness and patients’ quality-of-life
title_full_unstemmed Double-blind, randomized controlled trial comparing the use of microneedling alone versus chemical peeling alone versus a combination of microneedling and chemical peeling in the treatment of atrophic post-acne scars. An assessment of clinical effectiveness and patients’ quality-of-life
title_short Double-blind, randomized controlled trial comparing the use of microneedling alone versus chemical peeling alone versus a combination of microneedling and chemical peeling in the treatment of atrophic post-acne scars. An assessment of clinical effectiveness and patients’ quality-of-life
title_sort double-blind, randomized controlled trial comparing the use of microneedling alone versus chemical peeling alone versus a combination of microneedling and chemical peeling in the treatment of atrophic post-acne scars. an assessment of clinical effectiveness and patients’ quality-of-life
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501429/
https://www.ncbi.nlm.nih.gov/pubmed/34658706
http://dx.doi.org/10.5114/ada.2021.108913
work_keys_str_mv AT paklamisiuragata doubleblindrandomizedcontrolledtrialcomparingtheuseofmicroneedlingaloneversuschemicalpeelingaloneversusacombinationofmicroneedlingandchemicalpeelinginthetreatmentofatrophicpostacnescarsanassessmentofclinicaleffectivenessandpatientsqualityoflife
AT grochowiecmarcelina doubleblindrandomizedcontrolledtrialcomparingtheuseofmicroneedlingaloneversuschemicalpeelingaloneversusacombinationofmicroneedlingandchemicalpeelinginthetreatmentofatrophicpostacnescarsanassessmentofclinicaleffectivenessandpatientsqualityoflife
AT lesiakaleksandra doubleblindrandomizedcontrolledtrialcomparingtheuseofmicroneedlingaloneversuschemicalpeelingaloneversusacombinationofmicroneedlingandchemicalpeelinginthetreatmentofatrophicpostacnescarsanassessmentofclinicaleffectivenessandpatientsqualityoflife
AT bednarskiigora doubleblindrandomizedcontrolledtrialcomparingtheuseofmicroneedlingaloneversuschemicalpeelingaloneversusacombinationofmicroneedlingandchemicalpeelinginthetreatmentofatrophicpostacnescarsanassessmentofclinicaleffectivenessandpatientsqualityoflife